SUN PHARMACEUTICAL INDUSTRIES LTD. - Update On Halol Facility

This is with respect to our communication dated May 10, 2022 regarding the US FDA inspection at the Company's Halol (Gujarat) facility from April 26 to May 9, 2022 and issuance of Form-483 by US FDA with 10 observations. We now wish to inform you that the Company has received a communication from the US FDA indicating the inspection classification as 'Official Action Indicated' (OAI).